Notable Research Findings

The most groundbreaking individual studies from the latest supplement and nutrition research — in plain language, with the evidence caveats built in. Research signals worth knowing about, not health advice.

A six-month trial in 76 colorectal cancer patients found Lactobacillus supplementation significantly improved multiple markers of oxidative stress — but the benefit was seen in a very specific clinical population, not the general public.
- 2025-11-24
- RCT
- n = 76
- Journal of medical biochemistry
This is an early, well-designed study suggesting that gut bacteria may help manage oxidative damage after cancer surgery, but because it's among the first of its kind and limited to post-surgery CRC patients, the results can't yet be generalized to healthy people or other conditions.
Big effectLactobacillus amylovorus for Reduced Oxidative Stress
A probiotic blend improved constipation at 4 weeks in a trial — but the effect faded by week 8, suggesting ongoing intake may be needed.
- 2025-04-09
- RCT
- Journal of microbiology and biotechnology
This is among the first controlled studies to test Bifidobacterium lactis UABla-12 for constipation, but because the probiotic was a multi-strain formula, the specific contribution of that single strain remains unclear — treat this as early, not conclusive, evidence.
New evidenceBifidobacterium lactis UABla-12 for Improved Constipation
Systematic review of 11 studies links sesame oil to better cholesterol and blood sugar in diabetics — but the findings were inconsistent across trials.
- 2025-02-07
- Systematic Review
- Frontiers in nutrition
This is among the first systematic reviews on sesame oil for blood lipids and glycemic control, but the inconsistent results and narrow focus on diabetic and dyslipidemic patients mean the evidence is still too preliminary to apply broadly.
New evidenceSesame for Improved Blood Lipid Profile
Ginger supplementation linked to a 0.86 mg/L drop in CRP in a meta-analysis — but the dose that produced this effect wasn't specified.
- 2025-10-22
- Meta-Analysis
- Inflammopharmacology
This is one of the first meta-analyses to systematically assess ginger's anti-inflammatory effects, and the moderate CRP reduction is promising — but without knowing the dose or duration used in the underlying trials, it's hard to translate this into practical advice yet.
Big effectGinger for Reduced C-Reactive Protein Levels
In a 12-week trial, adding 335 mg/day vitamin C (with vitamin E) to resistance training slashed a key marker of oxidative damage by a massive effect size of 1.65 — but only in older women already diagnosed with sarcopenia.
- 2025-08-22
- RCT
- Medicine
This is the strongest signal yet from a small clinical trial that vitamin C can meaningfully reduce oxidative stress in a specific, vulnerable group, but the overall evidence across four studies is only moderate and mixed in effect size, so don't expect this magnitude in a healthy person.
Big effectVitamin C for Reduced Oxidative Stress
Injecting vitamin D3 directly into keloid scars improved their appearance in a small trial — but the effect was strongest when paired with platelet-rich plasma, not vitamin D alone.
- 2025-05-20
- RCT
- Archives of dermatological research
This is one of the first controlled tests of injected vitamin D3 for keloids, so the results are intriguing but far from ready for clinic — the study was small, unblinded, and the benefit may depend on combining treatments rather than vitamin D alone.
SurprisingVitamin D3 for Improved Vancouver Scar Scale
Anemic children given vitamin B12 shots saw hemoglobin jump by 2.7 g/dL versus 0.5 on oral pills — but the only trial behind that comparison had just one relevant group and was low quality.
- 2025-02-18
- Systematic Review
- Nutrition reviews
This single small study in hospitalized children suggests injected B12 might work faster than oral for severe deficiency, but the evidence is far too thin to change how you or your doctor think about B12 supplementation for the general population.
Myth-busterVitamin B12 for Increased Hemoglobin Levels
Magnesium plus vitamin D slashed hs-CRP by nearly two-thirds of a point in a meta-analysis of overweight and obese adults — but the effect vanished when vitamin E was substituted for vitamin D.
- 2025-09-01
- Systematic Review
- n = 509
- Frontiers in nutrition
This is an intriguing signal from a small meta-analysis (509 participants, only 3 studies) where the overall evidence strength is still rated low, so the impressive drop in inflammation should be treated as a promising hypothesis, not a settled fact.
Big effectMagnesium for Reduced C-Reactive Protein Levels
Vitamin E raised eGFR by a small but significant margin in a meta-analysis of drug-induced kidney injury — but the dose is a black box and the evidence is brand-new.
- 2025-04-14
- Systematic Review
- Frontiers in pharmacology
This is the first meta-analysis to suggest vitamin E may protect kidney function during drug injury, but because it’s an early finding with unspecified doses, it’s a clue to watch, not a reason to supplement.
Myth-busterVitamin E for Improved eGFR
A local vitamin D3 injection after braces kept teeth from drifting back over 3 months — but the same study found no effect on arch width or perimeter changes.
- 2025-03-05
- RCT
- The journal of contemporary dental practice
This is an early, small clinical trial suggesting a novel use for vitamin D in orthodontics, but the benefit was narrow (only one measure of relapse improved) and the approach (injected locally, not taken orally) doesn't translate to a supplement you can buy — so treat it as a curiosity, not a takeaway.
SurprisingVitamin D3 for Reduced Orthodontic Relapse
In 90 chronic hepatitis B patients, adding glutathione to standard antiviral therapy dropped ALT from ~349 to 31 U/L in three months — the control group only reached ~57 U/L.
- 2025-02-07
- RCT
- n = 90
- BMC gastroenterology
This is an unusually large improvement in a key liver enzyme, but the finding comes from a single, moderately-sized clinical trial in a specific patient group, so it doesn't yet tell us whether healthy people or those with milder liver issues would see anything similar.
Big effectGlutathione for Improved Alanine Aminotransferase Level
A 180-day trial found a blend of four herbs — including milk thistle — improved liver enzymes in healthy adults, but the effect can't be pinned on thistle alone.
- 2026-01-23
- Clinical Trial
- n = 130
- Frontiers in nutrition
This is the first solid clinical trial linking milk thistle (as part of a mix) to lower alkaline phosphatase, but the combination product means we don't know how much thistle contributed — and the overall evidence for thistle alone on this marker is still modest and based on small effects.
New evidenceThistle for Reduced Alkaline Phosphatase Level
Red grape flavonoids significantly lowered a liver enzyme in NAFLD patients — but didn't touch inflammation or scarring
- 2025-09-15
- Systematic Review
- n = 689
- Frontiers in nutrition
This meta-analysis of 689 people with fatty liver disease found a moderate, consistent drop in AST (a marker of liver stress), but the benefit stopped there — inflammatory markers and fibrosis scores didn't budge, and the evidence rests on only four studies, so the picture is promising but far from settled.
Big effectRed Grape for Reduced Aspartate Aminotransferase Level
A probiotic blend doubled the response rate for IBS symptoms at 28 days — but the benefit came from two strains together, not BB-12 alone, and the overall gut microbiome barely budged.
- 2025-11-18
- RCT
- Journal of gastroenterology and hepatology
This is one of the first rigorous trials on this specific probiotic pairing, so the results are promising but far from settled — the real-world impact depends on whether the combination, not just BB-12, drives the effect, and other measures like overall microbiome composition didn't change.
Big effectBifidobacterium animalis subsp. lactis BB-12 for Improved Irritable Bowel Syndrome Symptoms
A live Lactobacillus crispatus product significantly reduced bacterial vaginosis recurrence — but efficacy was incomplete and hinged on baseline microbiota.
- 2026-04
- RCT
- Cell host & microbe
This is one of the first rigorous trials to show that a specific Lactobacillus strain can prevent BV recurrence, but the incomplete effect and novelty mean it's not yet a proven solution for everyone.
Big effectLactobacillus crispatus for Reduced Recurrence of Bacterial Vaginosis
Adding saw palmetto to a standard BPH drug outperformed the drug alone in a 12-month trial — but the extra benefit only kicked in after three months, and the study didn't test saw palmetto by itself.
- 2025-10-16
- RCT
- The Prostate
This study suggests saw palmetto may have a role as an add-on therapy for men already taking alfuzosin for enlarged prostate symptoms, but it doesn't change the overall weak evidence for saw palmetto as a standalone treatment — and the trial's design (unclear blinding and funding) means the result should be weighed cautiously.
Myth-busterSaw Palmetto for Improved Lower Urinary Tract Symptoms
A probiotic reduced dry eye symptom scores in a 68-person trial — but the effects were tied to a single strain and haven't been replicated yet.
- 2025-04-10
- RCT
- n = 68
- Biomedicines
This is the first controlled trial linking Streptococcus thermophilus iHA318 to dry eye relief, so while the results are promising, they come from a small, single study that needs independent confirmation before you can count on it.
New evidenceStreptococcus thermophilus SL-21 for Improved Dry Eye Symptoms
A 12-week trial added a specific Bifidobacterium strain to metformin and saw a statistically significant drop in HbA1c — but only in a small, early study on type 2 diabetes patients.
- 2026-01
- RCT
- Food science & nutrition
This is the first randomized trial to show that Bifidobacterium longum subsp. longum BL21 might help lower blood sugar control marker HbA1c in type 2 diabetes, but it's a single early result in a specific clinical population — so treat it as promising but far from proven.
New evidenceBifidobacterium longum subsp. longum for Improved Glycemia
A systematic review found Lactobacillus rhamnosus TOM 22.8 at 10×10⁹ CFU/day for 10 days significantly reduced bacterial vaginosis recurrence — but only one strain had strong data, and the optimal dose is still unclear.
- 2025-03-10
- Systematic Review
- Narra J
This is among the first indexed reviews on this exact strain-dosing combination, so while the result is promising for recurrence prevention, it's a single early signal — not a settled recommendation.
New evidenceLactobacillus jensenii LBV 116 for Reduced Recurrence of Bacterial Vaginosis
In a 12-week trial, a Bifidobacterium infantis strain slashed respiratory infection incidence to 15% versus 42% in preschoolers — but the effect comes from a single, early study.
- 2026-01-05
- Clinical Trial
- Frontiers in nutrition
This large effect size is eye-catching, but because it's one of the first trials on this specific pairing, the result needs replication before we can trust it broadly — especially in adults or other age groups.
Big effectBifidobacterium infantis for Reduced Respiratory Infections
A placebo-controlled trial found a yogurt bacterium significantly reduced gut symptom scores — and also linked it to better sleep and immune markers, though these extra findings come from a single early study.
- 2026-01
- RCT
- Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association
This is among the first human trials on this specific probiotic strain, so while the gut symptom improvement is statistically significant, the broader claims about sleep and immunity are less certain and need independent replication.
SurprisingLactobacillus bulgaricus LB42 for Improved Gastrointestinal Symptoms
Curcumin associated with healthier cholesterol in a new umbrella review — but the studies it pooled were too weak to be convincing
- 2025-06-05
- Systematic Review
- Frontiers in pharmacology
This review suggests curcumin may improve lipid profiles, but because the included trials had poor methodological quality, the finding is far from definitive. It's one of the first comprehensive looks at curcumin and cholesterol, so more high-quality research is needed.
TrendingTurmeric for Improved Blood Lipid Profile
Chanca Piedra as an add-on to shockwave therapy improved stone clearance for lower pole kidney stones — but this is the first systematic review on the combo, so the evidence is still early and the dose wasn't specified.
- 2025-07
- Systematic Review
- Actas urologicas espanolas
This systematic review is the first to compile data on Chanca Piedra specifically as an adjunct to ESWL for lower pole stones, making the finding promising but preliminary — the exact dose remains unknown, and the overall body of evidence on this pairing is still thin.
New evidenceChanca Piedra for Improved Stone-Free State
Red sage cut creatinine and multiple inflammation markers in 1,970 people with diabetic kidney disease — but this is the first meta-analysis on the pairing, so the picture is far from settled.
- 2025-09-12
- Systematic Review
- n = 1,970
- Frontiers in pharmacology
This is the first solid systematic review linking red sage (Salvia miltiorrhiza) to kidney protection in diabetics, but because the evidence is still early and the underlying 21 trials varied in quality, the result is promising — not definitive.
New evidenceRed Sage for Reduced Serum Creatinine Levels
Caffeine plus taurine beat either alone for anaerobic capacity in a meta-analysis — but the same review found no boost to endurance or athletic performance.
- 2025-10
- Systematic Review
- Journal of the International Society of Sports Nutrition
This is the first systematic analysis to suggest a real synergy between caffeine and taurine for short bursts of effort, but with no effect on other fitness measures and no prior studies to lean on, one meta-analysis does not make a settled fact.
New evidenceTaurine for Improved Anaerobic Capacity
A meta-analysis found that toothpaste containing Bifidobacterium animalis BS-01 reduced plaque by a moderate amount after 3 months — but the studies behind it varied so much that the true effect is uncertain.
- 2025-10-20
- Systematic Review
- Frontiers in oral health
This is the first solid evidence linking this specific probiotic to better oral health, but with only one meta-analysis and high inconsistency across the included studies, it's too early to treat this as a reliable benefit.
New evidenceBifidobacterium animalis BS-01 for Improved Plaque Index
Quercetin ranked highest among plant compounds for reducing RA pain in a meta-analysis — but the evidence is still sparse.
- 2025-02-05
- Systematic Review
- Frontiers in pharmacology
This analysis suggests quercetin may be the most effective plant compound for pain relief in rheumatoid arthritis, but with few studies and no specified dose, it's far from a proven treatment.
TrendingQuercetin for Reduced Visual Analog Scale Score
Portulaca oleracea (purslane) raised urinary citrate and lowered calcium in a systematic review of kidney stone studies — but the evidence is still thin.
- 2025-10-20
- Systematic Review
- Naunyn-Schmiedeberg's archives of pharmacology
This is among the first indexed studies to look at purslane for kidney stone risk, so while the direction is promising, a single systematic review of small trials isn't enough to act on yet.
New evidencePortulaca for Increased Urinary Citrate Level
Probiotics cut UTI recurrence risk in kids — but an adult study found minimal effect, highlighting age-specific results.
- 2025-11-26
- Systematic Review
- Annals of medicine and surgery (2012)
This systematic review offers early evidence that Bifidobacterium bifidum HA-132 and other probiotics may help reduce UTI recurrence in children, but the finding is limited by mixed results in adults and the fact that this is among the first indexed studies on this specific pairing — so treat it as promising but far from settled.
New evidenceBifidobacterium bifidum HA-132 for Reduced Recurrence of Urinary Tract Infections
Berberine cut triglycerides by roughly 0.37 mmol/L in a meta-analysis of 4 trials — but only 2 of those studies saw a benefit, leaving the overall evidence low.
- 2025-07-16
- Systematic Review
- Frontiers in pharmacology
This pooled result is a signal worth watching, not a settled fact: a systematic review found berberine lowered triglycerides, fasting glucose, and waist circumference in metabolic syndrome, yet half the individual studies saw no effect, and the overall evidence grade is weak.
TrendingBerberine for Reduced Triglyceride Levels